Eric Hansen, DO
Infectious Disease · Cape May Court House, NJNPI 1508956533
Payments from drug & device makers
Across 56 payments — averaging $21.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$821
- Smith+Nephew$97
- Shionogi Inc$74
- Merck$66
- Integra Lifesciences Corporation$29
- Paratek Pharmaceuticals, Inc.$28
- plus $66 from 4 others
What the payments were for
- Food & beverage$1,16999%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $821 |
| Smith+Nephew | 2 | $97 |
| Shionogi Inc | 1 | $74 |
| Merck | 4 | $66 |
| Integra Lifesciences Corporation | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Cashflow Solutions, LLC | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Gilead | 1 | $15 |
How this compares
$1,181 in reported general payments places this provider in the 55th percentile of 334 infectious disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 34 | $32,158 |
| Cefepime Hcl | 18 | $6,102 |
| Meropenem | 12 | $3,414 |
| Doxycycline Hyclate | 32 | $334 |
| Clindamycin Hcl | 23 | $279 |
| Ciprofloxacin Hcl | 31 | $269 |
| Cephalexin | 26 | $226 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $173 |
| Triamcinolone Acetonide | 25 | $159 |
| CefuroximeCefuroxime Axetil | 11 | $111 |
| Amoxicillin | 19 | $86 |
| Mupirocin | 16 | $65 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Cape May Court House
- Jihad SlimNewark$6.7M
- Ronald NahassHillsborough$6.1M
- Bindu BalaniHackensack$4.9M
- Suraj SaggarEnglewood$2.9M
- Christopher LucastiSomers Point$2.8M
- Edward LiuNeptune$2.6M
- Keith GottesdienerRahway$2.1M
- Amna YaqubFlemington$1.4M
- Shobha SwaminathanNewark$1.4M
- Mohamed RabbatPaterson$760K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.